| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-07 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |